The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood
Abstract
AIMS: Debate continues about whether the association between cannabis use in adolescence and common mental disorders is causal. Most reports have focused on associations in adolescence, with few studies extending into adulthood. We examine the association from adolescence until the age of 29 years in a representative prospective cohort of young Australians. DESIGN: Nine-wave, 15-year representative longitudinal cohort study, with six waves of data collection in adolescence (mean age 14.9-17.4 years) and three in young adulthood (mean age 20.7, 24.1 and 29.1 years). PARTICIPANTS: Participants were a cohort of 1943 recruited in secondary school and surveyed at each wave when possible from mid-teen age to their late 20s. SETTING: Victoria, Australia. MEASUREMENTS: Psychiatric morbidity was assessed with the Revised Clinical Interview Schedule (CIS-R) at each adolescent wave, and as Composite International Diagnostic Interview (CIDI)-defined ICD-10 major depressive episode and anxiety disorder at 29 years. Frequency of cannabis use was measured in the past 6 months in adolescence. Cannabis use frequency in the last year and DSM-IV cannabis dependence were assessed at 29 years. Cross-sectional and prospective associations of these outcomes with cannabis use and dependence were estimated as odds ratios (OR), using multivariable logistic regression models, with the outcomes of interest, major depressive episode (MDE) and anxiety disorder (AD) at 29 years. FINDINGS: There were no consistent associations between adolescent cannabis use and depression at age 29 years. Daily cannabis use was associated with anxiety disorder at 29 years [adjusted OR 2.5, 95% confidence interval (CI):< 1.2-5.2], as was cannabis dependence (adjusted OR 2.2, 95% CI: 1.1-4.4). Among weekly+ adolescent cannabis users, those who continued to use cannabis use daily at 29 years remained at significantly increased odds of anxiety disorder (adjusted OR 3.2, 95% CI: 1.1-9.2). CONCLUSIONS: Regular (particularly daily) adolescent cannabis use is associated consistently with anxiety, but not depressive disorder, in adolescence and late young adulthood, even among regular users who then cease using the drug. It is possible that early cannabis exposure causes enduring mental health risks in the general cannabis-using adolescent population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the higher risk for depression and anxiety in adolescents that continue to smoke until age 29 years was also confirmed by Degenhardt et al, 38 suggesting that even the chronic use in young age is detrimental for mental health.”
From Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood (2019) · cites this paper as [38]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
The detection of psychiatric illness by questionnaire
Levy, R. (1973) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(73)90039-1 · Cited by 2,707
The world health organization composite international diagnostic interview short-form (CIDI-SF)
Kessler, R. C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H. (1998) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.47 · Cited by 2,242
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Psychiatric disorders in America
Robins, L. N. (1991) · Medical Entomology and Zoology · Cited by 1,567
Research works printed but not linked: 1
- Institute of Medicine, 1996, Pathways of Addiction
Cited by
Sorted by citations
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4500 · Cited by 914
Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014) · Psychological Medicine · doi:10.1017/s0033291713001438 · Cited by 589
“We determined a score of 8 or more on the NOS to indicate ‘high methodological quality’.”
BackgroundMethodResultInfluentialLower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Foll, B. L., Hall, W., Rehm, J. T., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 474
Self-citationCannabis Use and Risk of Psychiatric Disorders
Blanco, C., Hasin, D. S., Wall, M. M., Flórez‐Salamanca, L., Hoertel, N., Wang, S., Kerridge, B. T., & Olfson, M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3229 · Cited by 350
Kedzior, K. K., & Laeber, L. T. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-136 · Cited by 309
“, 2013; VAHCS, Australia [41] AD at 29 to ≥ weekly vs.”
Influential
Metadata
- Authors
- Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C.
- Affiliations
- The University of Melbourne (AU)
- Royal Children's Hospital (AU)
- UNSW Sydney (AU)
- The University of Queensland (AU)
- Corresponding author
- Degenhardt, Louisa
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2012-10-18
- Volume
- 108
- Issue
- 1
- Pages
- 124-133
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2111932815
- Cited by
- 237
- References
- 49
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 12 · 2023: 8 · 2022: 20 · 2021: 15 · 2020: 22 · 2019: 17 · 2018: 25 · 2017: 22 · 2016: 18 · 2015: 22 · 2014: 25 · 2013: 9 · 2012: 3
- FWCI
- 13.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- adolescent cannabis use, cannabis use disorder, anxiety disorders, major depressive episode, common mental disorders, early adulthood, daily cannabis use, long-term mental health outcomes, causal relationship
- MeSH terms
- Adolescent, Adult, Anxiety Disorders, Marijuana Abuse, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Longitudinal Studies, Male, Marijuana Smoking, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review